🟢 Omada Health is trading 6.4% up in after-hours trading after Q2 revenue beat consensus estimates

Omada Health is trading 6.4% up at $20.78 after reporting second-quarter revenue of $87.8 million, above the $80.0 million consensus estimate.

• Revenue rose 43% year over year; $5 million in net income and record gross margins supported its first GAAP-profitable period.
• Wei-Li Shao will become CEO on January 1, 2027, while Sean Duffy transitions to Executive Chair.